SEROQUELXR (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the SEROQUEL drug offered from AstraZeneca Pharmaceuticals LP. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
NON-PROPRIETARY NAME: | Quetiapine fumarate |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-10-02 |
END MARKETING DATE: | 0000-00-00 |
SEROQUEL XR HUMAN PRESCRIPTION DRUG Details:
Item Description | SEROQUEL XR from AstraZeneca Pharmaceuticals LP |
LABELER NAME: | AstraZeneca Pharmaceuticals LP |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2014-10-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0310-0297_02bb1367-177e-43a2-b5c6-b8acf882faa7 |
PRODUCT NDC: | 0310-0297 |
APPLICATION NUMBER: | NDA022047 |